Intellipharmaceuticals International Inc.
IPCI
IPCI was delisted on the 20th of March, 2019.
19 hedge funds and large institutions have $2.15M invested in Intellipharmaceuticals International Inc. in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.
0% more funds holding
Funds holding: 19 → 19 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
57% less capital invested
Capital invested by funds: $5.01M → $2.15M (-$2.86M)
99% less call options, than puts
Call options by funds: $4K | Put options by funds: $506K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$107K |
| 2 |
NCCM
Nine Chapters Capital Management
Short Hills,
New Jersey
|
+$78.9K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$75.9K |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$30.2K |
| 5 |
Morgan Stanley
New York
|
+$7.86K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$3.14M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$205K |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$60.4K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$60.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$48.5K |
IPCI Hedge Fund Activity: Q2 2015 in Review
19 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Intellipharmaceuticals International Inc. (IPCI) for Q2 2015, worth a combined $2.15M — down 57% from $5.01M a quarter earlier.
Fund positioning in IPCI was balanced in Q2 2015: 4 funds opened new positions, 4 closed out, 5 added to existing stakes and 5 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $107K. The largest seller was Tekla Capital Management, cutting an estimated $3.14M.
- 19 institutional investors held Intellipharmaceuticals International Inc. (IPCI) as of Q2 2015, unchanged from Q1 2015.
- Funds reported $2.15M of Intellipharmaceuticals International Inc. stock for Q2 2015, down 57% quarter-over-quarter.
- 4 funds opened new Intellipharmaceuticals International Inc. positions in Q2 2015 and 4 closed out, a net change of 0 holders.
- The largest Intellipharmaceuticals International Inc. buyer in Q2 2015 was Susquehanna International Group, an estimated $107K added.
- The largest Intellipharmaceuticals International Inc. seller in Q2 2015 was Tekla Capital Management, an estimated $3.14M sold.
Based on aggregated 13F filings for Q2 2015.